In order to effectively and safely prevent and reduce inflammation of at least a part of a skin of a body part as a reaction to the administration of a vascular endothelial growth factor inhibitor the present invention suggests an apparatus comprising at least one application unit, wherein the application unit has a receiving section for receiving a body part of a human body being disposed within an interior space of the application unit, wherein the application unit comprises at least one light emitter for applying light onto at least a part of the skin of the received body part within receiving section of the apparatus, wherein the application unit is configured to apply light onto at least a part of the skin of the received body part with a wavelength of between 400 nm to 500 nm, preferably a wavelength of between 430 nm to 480 nm, most preferred a wavelength of between 450 nm to 460 nm.
